Related references
Note: Only part of the references are listed.Postoperative bleeding risk for oral surgery under continued rivaroxaban anticoagulant therapy
Henning Hanken et al.
CLINICAL ORAL INVESTIGATIONS (2016)
An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery
S. Johnston
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2016)
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
James D. Douketis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
Matthew W. Sherwood et al.
CIRCULATION (2014)
Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry
Jan Beyer-Westendorf et al.
EUROPEAN HEART JOURNAL (2014)
Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials
Thomas Vanassche et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Evaluation of postextraction bleeding incidence to compare patients receiving and not receiving warfarin therapy: a cross-sectional, multicentre, observational study
Hiroshi Iwabuchi et al.
BMJ OPEN (2014)
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
Hein Heidbuchel et al.
EUROPACE (2013)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Management of dental extraction in patients undergoing anticoagulant treatment
Christian Bacci et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
